Andropause in Iranian Men: Related Factors and Consequences; A Systematic Review
Men's Health Journal,
Vol. 3 No. 1 (2019),
13 April 2019
,
Page e13
https://doi.org/10.22037/mhj.v3i1.33117
Abstract
Introduction: Andropause is a syndrome with a slow progression that is associated with androgen deficiency in older men. This study aimed to collect all scientific data about the factors that cause the occurrence of andropause in Iranian men as well as the aspects of life which can be affected by this disorder. Materials and Methods: Searching was conducted in international databases including MedLine, Scopus, Web of Science, ProQuest, and national database (SID) from inception until December 2019. Retrieved studies were reviewed by two researchers independently and selected studies were summarized in a table. Results: Finally, 21 related studies were included and summarized information showed that andropause can be negatively affected by age, lower testosterone levels, smoking, lower economic status, lower educational level, and poor employment status. Some studies have also implied that there is a significant correlation between andropause and quality of life, sleep quality, depression, anxiety, marital dissatisfaction, urinary incontinence, coronary heart disease, and metabolic syndrome. Conclusion: According to the collected data in this present study, Iranian studies have covered a wide variety of complications and related factors in the field of andropause but, we still lake some studies about other aspects of andropause such as musculoskeletal impairment, erectile dysfunction, memory and cognitive disorders, skin and hair disorders, decreased libido, and other mood disorders.
How to Cite
References
Paul, U.K., A.K. Bhattacharyya, and S.K. Pal, Andropause: The Missing Health. 2017, Citeseer.
Najafabady, M.T., et al., The andropause symptoms and its relationship with the blood testosterone: a preliminary cross-sectional study in Ahvaz, Iran. Jundishapur J Chronic Dis Care, 2013. 2: p. 41-45.
Khosravi, S., et al., Are andropause symptoms related to depression? Aging Clinical and Experimental Research, 2015. 27(6): p. 813-820.
Sofimajidpour, H., T. Teimoori, and F. Gharibi, The effect of testosterone on men with andropause. Iranian Red Crescent Medical Journal, 2015. 17(12).
Afsharnia, E., et al., The severity of hypogonadism symptoms and its risk factors among male employees of Tehran University of Medical Sciences. The Aging Male, 2018: p. 1-7.
Heidari, R., et al., Can testosterone level be a good predictor of late‐onset hypogonadism? Andrologia, 2015. 47(4): p. 433-437.
Afsharnia, E., et al., Examining the effect of the computer-based educational package on quality of life and severity of hypogonadism symptoms in males. The Aging Male, 2018. 21(2): p. 85-92.
Madani, A.H., et al., A survey on relative frequency of metabolic syndrome and testosterone deficiency in men with erectile dysfunction. International urology and nephrology, 2012. 44(3): p. 667-672.
Afsharnia, E., et al., The quality of life and related factors in men with andropause. Journal of hayat, 2016. 22(1): p. 38-49.
Rezaei, N., A. Azadi, and R. Pakzad, Prevalence of andropause among Iranian men and its relationship with quality of life. The Aging Male, 2018: p. 1-8.
Lari, M.A., et al., Depression, testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV infection. AIDS and Behavior, 2012. 16(8): p. 2236-2243.
Hakimi, S., et al., The Prevalence of Andropause Symptoms and the Role of Social Determinants of Health on its Severity in Healthy Men: A Community-based Study in Northwest Iran. Crescent Journal of Medical and Biological Sciences. 6(3).
Mousavi, M., et al., Exploratory Study of Andropause Syndrome in 40-65 Years in Arak: A Cross Sectional Study. Journal of Family & Reproductive Health, 2018. 12(3): p. 142.
Aliakbari Dehkordi, M. and Z. Azizi, Determining Psychological Dimensions of Andropause: Comparison of Mental Health between Men with Andropause and Normal Men. Journal of Research in Behavioural Sciences, 2019. 17(1): p. 130-138.
Samipoor, F., et al., Awareness and experience of andropause symptoms in men referring to health centers: a cross-sectional study in Iran. The Aging Male, 2017. 20(3): p. 153-160.
AHMADLOU, N., et al., Impact of scattered radiation on testosterone deficiency and male hypogonadism in rectal cancer treated with external beam pelvic irradiation. 2010.
Faramarzia, H., et al., Hypogonadism and associated factors in patients with HIV infection based on total and free testosterone. Shiraz E-Med J, 2014. 15: p. e19734.
Karimi, M., et al., Comparative study of hypogonadism in beta-thalassemia intermedia patients with and without hydroxyurea. Hematology, 2012. 17(2): p. 122-124.
Mirzaei, M.R., M. Amini, and A. Aminorroaya, The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 2012. 17(7): p. 602.
Hosseini, M.-S., et al., Comparison of Quality of Life and Blood Glucose Control in Type 2 Diabetic Patients with and without Hypogonadism: Case-Control Study. Journal of Military Medicine, 2019. 20(6): p. 618-625.
Samipoor, F., et al., The association between hypogonadism symptoms with serum testosterone, FSH and LH in men. The Aging Male, 2018. 21(1): p. 1-8.
Sayehmiri, K., et al., The prevalence of hypogonadism in patients with thalassemia major in Iran–a systematic review and meta-analysis study. Journal of Shahrekord University of Medical Sciences, 2016. 18(5): p. 140-151.
Lee, J.G., et al., Evaluation of the effectiveness and safety of a daily dose of 5 mg of tadalafil, over an 8-week period, for improving quality of life among Korean men with andropause symptoms, including erectile dysfunction: A pilot study. Medicine, 2018. 97(51).
Wang, C., et al., Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. European journal of endocrinology, 2008. 159(5): p. 507-514.
O’BRIEN, J.H., et al., Erectile dysfunction and andropause symptoms in infertile men. The Journal of urology, 2005. 174(5): p. 1932-1934.
Taher, A., Proportion and acceptance of andropause symptoms among elderly men: a Study in Jakarta. Acta Med Indones, 2005. 37(2): p. 82-6.
O’Leary, M.P., Development of an index to evaluate symptoms in men with androgen deficiency. Reviews in urology, 2003. 5(Suppl 1): p. S11.
Heinemann, L.A., et al., The Aging Males' Symptoms (AMS) scale: update and compilation of international versions. Health and quality of life outcomes, 2003. 1(1): p. 15.
Samaras, N., et al., Andropause: A review of the definition and treatment. European Geriatric Medicine, 2012. 3(6): p. 368-373.
Belchetz, P.E., Hormonal treatment of postmenopausal women. New England Journal of Medicine, 1994. 330(15): p. 1062-1071.
Tan, R.S. and S.-J. Pu, Is it andropause? Recognizing androgen deficiency in aging men. Postgraduate medicine, 2004. 115(1): p. 62-66.
GRAY, A., et al., Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. The Journal of Clinical Endocrinology & Metabolism, 1991. 73(5): p. 1016-1025.
MORALES, A., J.P. Heaton, and C.C. CARSON III, Andropause: a misnomer for a true clinical entity. The Journal of urology, 2000. 163(3): p. 705-712.
- Abstract Viewed: 298 times
- pdf Downloaded: 184 times